Tom Friedman’s Pure Invention opens at Kemper Art Museum
Sculptor transforms mundane consumer products into playful yet meticulously crafted artworks.
Legal scholar, culture critic to speak for Assembly Series
Richard Epstein and bell hooks will speak Oct. 31 and Nov. 1, respectively.
It’s to dine for
Photo by Kevin LowderFirst-year law students practice the art of fine dining from WUSTL law alumna Joan Newman (center).
Soviets had Cold War chess cartel
New research from WUSTL economists offers strong evidence that Soviet chess masters very likely engaged in collusion.
Sing, sing a song
Photo by Kevin LowderThe Aristocats perform Oct. 12 in Graham Chapel as part of a concert to benefit Gulf Coast rebuilding efforts.
High-energy clamp simplifies heart surgery
Using radiofrequency devices, School of Medicine heart surgeons have shortened atrial fibrillation surgery and made it easier to perform.
Danforth talk available
The second program in the Danforth Lecture Series featuring former Sen. John C. “Jack” Danforth speaking on “Faith & Politics,” which was held Oct. 16 in Graham Chapel, now can be accessed on the Web.
Siteman Cancer Center gains nationally recognized leader in cancer prevention
ColditzGraham A. Colditz, M.D., Dr.P.H., has been named the Niess-Gain Professor and associate director of Prevention and Control at the Siteman Cancer Center at the School of Medicine and Barnes-Jewish Hospital. He will have overall responsibility for overseeing research, education, and community outreach in cancer prevention sponsored by the Center.
Naturally occurring enzyme can break down key part of Alzheimer’s plaques
Scientists have identified a naturally occurring enzyme that can break down a key component of the brain plaques characteristic of Alzheimer’s disease. The finding may provide researchers with new opportunities to understand what goes wrong in the brains of Alzheimer’s patients and could one day help them seek new therapies.
Neuroscientists awarded $14 million in two grants
The School of Medicine, a research leader in Alzheimer’s disease, Parkinson’s disease, stroke and schizophrenia, will be among the first recipients of a major new National Institutes of Health (NIH) grant to facilitate study of nervous system disorders. The NIH Blueprint for the Neurosciences Grant will provide $8 million to the University over five years.
View More Stories